At this event, we will focus on cardiovascular diseases (CVD) and Metabolic diseases.

Cardiovascular disease (CVD) continues to be a leading cause of mortality worldwide, highlighting the critical need for early diagnosis, innovative therapies, and tailored interventions.

 

Closely linked to cardiovascular health, metabolic diseases such as diabetes, obesity, and dyslipidemia often serve as major risk factors, contributing to the onset and progression of heart disease.

Together, these interconnected disease groups represent some of the most urgent challenges facing global healthcare.

In the Nordics, we have many innovative companies leading the way in advanced research and the development of therapeutic solutions in these large indications. Their groundbreaking efforts have and can attracted  interest from major biopharma firms looking to invest in new assets, for treating and preventing these conditions.

 

At this event, leading Nordic companies specializing in cardiovascular and metabolic diseases will present their latest advancements, providing a glimpse into the future of healthcare in these critical areas.